These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1352465)
1. Angiopeptin: a treatment for accelerated myointimal hyperplasia? Foegh ML J Heart Lung Transplant; 1992; 11(3 Pt 2):S28-31. PubMed ID: 1352465 [TBL] [Abstract][Full Text] [Related]
2. Peptide inhibition of myointimal proliferation by angiopeptin, a somatostatin analogue. Lundergan CF; Foegh ML; Ramwell PW J Am Coll Cardiol; 1991 May; 17(6 Suppl B):132B-136B. PubMed ID: 1673136 [TBL] [Abstract][Full Text] [Related]
3. Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit. Foegh ML; Asotra S; Conte JV; Howell M; Kagan E; Verma K; Ramwell PW J Vasc Surg; 1994 Jun; 19(6):1084-91. PubMed ID: 7911163 [TBL] [Abstract][Full Text] [Related]
4. Angiopeptin: experimental and clinical studies of inhibition of myointimal proliferation. Foegh ML; Ramwell PW Kidney Int Suppl; 1995 Dec; 52():S18-22. PubMed ID: 8587276 [TBL] [Abstract][Full Text] [Related]
5. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619. Zhao Y; Foegh ML Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208 [TBL] [Abstract][Full Text] [Related]
6. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Santoian ED; Schneider JE; Gravanis MB; Foegh M; Tarazona N; Cipolla GD; King SB Circulation; 1993 Jul; 88(1):11-4. PubMed ID: 8100489 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Lundergan C; Foegh ML; Vargas R; Eufemio M; Bormes GW; Kot PA; Ramwell PW Atherosclerosis; 1989 Nov; 80(1):49-55. PubMed ID: 2574977 [TBL] [Abstract][Full Text] [Related]
8. Angiopeptin inhibition of myointimal hyperplasia after balloon angioplasty of large arteries in hypercholesterolaemic rabbits. Howell MH; Adams MM; Wolfe MS; Foegh ML; Ramwell PW Clin Sci (Lond); 1993 Aug; 85(2):183-8. PubMed ID: 8104753 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group. Emanuelsson H; Beatt KJ; Bagger JP; Balcon R; Heikkilä J; Piessens J; Schaeffer M; Suryapranata H; Foegh M Circulation; 1995 Mar; 91(6):1689-96. PubMed ID: 7882475 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of somatostatin and angiopeptin on cell proliferation. Alderton F; Lauder H; Feniuk W; Fan TP; Humphrey PP Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549 [TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Eriksen UH; Amtorp O; Bagger JP; Emanuelsson H; Foegh M; Henningsen P; Saunamäki K; Schaeffer M; Thayssen P; Orskov H Am Heart J; 1995 Jul; 130(1):1-8. PubMed ID: 7611096 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide. Foegh ML; Khirabadi BS; Chambers E; Amamoo S; Ramwell PW Atherosclerosis; 1989 Aug; 78(2-3):229-36. PubMed ID: 2571335 [TBL] [Abstract][Full Text] [Related]
13. The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit. Hong MK; Bhatti T; Matthews BJ; Stark KS; Cathapermal SS; Foegh ML; Ramwell PW; Kent KM Circulation; 1993 Aug; 88(2):638-48. PubMed ID: 8101773 [TBL] [Abstract][Full Text] [Related]
14. Rat heart smooth muscle cells express high and low affinity receptors for somatostatin-14, which are involved in regulation of cell proliferation. Leszczynski D; Zhao Y; Cathapermal S; Nilsson J; Foegh ML Life Sci; 1993; 53(22):1663-74. PubMed ID: 7901726 [TBL] [Abstract][Full Text] [Related]
18. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis. Mennander A; Räisänen A; Paavonen T; Häyry P Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036 [TBL] [Abstract][Full Text] [Related]
19. Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation. Bauters C; Van Belle E; Wernert N; Delcayre C; Thomas F; Dupuis B; Lablanche JM; Bertrand ME; Swynghedauw B Circulation; 1994 May; 89(5):2327-31. PubMed ID: 7910119 [TBL] [Abstract][Full Text] [Related]
20. Angiopeptin as a potent inhibitor of myointimal hyperplasia. Systemic injection and local administration via impregnation in a biodegradable polymeric gel. Matsuda T; Motomura N; Oka T ASAIO J; 1993; 39(3):M512-7. PubMed ID: 7903567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]